| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO | CEO | Interim CEO
1 company
Faga Daniel serves as a President, CEO at ANAB. Across recent SEC filings that breaks down to 0 buys and 16 sells. Those positions are worth an estimated $31.8M at current prices.
Historically, Faga Daniel's trades have earned a middling insider score of 62/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +22.7%.
The biggest single holding is ANAB (~$31.8M) as President, CEO. The recent filings there lean toward selling, a net 212,277 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | ANAB Anaptysbio, Inc. | President, CEO | Sell | 17,679 | $61.61 | $1,089,198.74 | -3.4% | +56.0% | - | |
| Jan 8, 2026 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 14,281 | $44.71 | $638,503.51 | -2.9% | -0.2% | - | |
| Jan 7, 2026 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 9,202 | $45.11 | $415,102.22 | -1.9% | -8.4% | - | |
| Jan 5, 2026 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 15,309 | $43.26 | $662,267.34 | -3.2% | -3.7% | - | |
| Mar 25, 2024 | ANAB Anaptysbio, Inc | CEO | Sell | 148,940 | $22.76 | $3,389,452.02 | -16.6% | +14.0% | -12.6% | |
| Jan 8, 2024 | ANAB Anaptysbio, Inc | CEO | Sale+OE | 6,866 | $21.81 | $149,747.46 | -0.8% | -8.3% | -34.3% |